Published in Vaccine Weekly, August 2nd, 2006
Study 1: Two commercial blood tests have higher specificity than the tuberculin skin test.
According to recent research from Italy, "Two commercial blood assays for the diagnosis of latent tuberculosis infection - T-SPOT.TB and QuantiFERON-TB Gold - have been separately compared with the tuberculin skin test. Our aim was to compare the efficacy of all three tests in the same population sample. We did a prospective study in 393 consecutively enrolled patients who were tested simultaneously with T-SPOT.TB and QuantiFERON-TB Gold because of suspected latent or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.